Immunocellular Therapeutics in Calabasas has announced that it is on the hunt for a buyer.
Health care workers staged a protest at Kaiser Permanente’s Woodland Hills hospital on Thursday in response to the company’s plan for layoffs at its call center there. “We’re out here today for our patients and to help our co-workers keep our jobs,” Danielle Gavison, a 15-year employee of Kaiser’s Woodland Hills call center, told the Business Journal.
A state report lists nearly 1,200 pending layoffs at Adventist Health hospitals across the state, including hundreds at Adventist Health Glendale and Adventist Health Simi Valley.
The owner of Harbor Freight Tools has donated $50 million to Cedars-Sinai to create an institute for research and innovative practices in cardiology and cardiovascular surgery.
Former Eli Lilly & Co. executive Dr. David Kendall has been appointed chief medical officer at MannKind Corp., the Westlake Village biotech announced Tuesday.
The population health management subsidiary of Apollo Medical Holdings Inc., Network Medical Management, has reached an agreement with a Pasadena-based clinic network that will add the data of more than 100,000 patients to Network Medical’s platform.
Second Sight Medical Products Inc. announced Monday that it tripled the number of implants of its prosthetic eyesight device in the fourth quarter over the same period the previous year, sending the company’s stock up almost 13 percent against sharp losses for the market overall.
Amgen Inc. released fourth-quarter and full-year financial results that missed Wall Street expectations on both earnings and revenue, after which its stock slipped in after-hours trading.
Apple Inc. has reached out to Cedars-Sinai and Dignity Health to debut a system to allow patients to securely access medical records on their iPhones.
Providence Tarzana Medical Center received a $4 million donation from Allison Clago, a member of the hospital’s board of governors, in a signing ceremony on Wednesday at the Providence Tarzana Foundation office.
Endonovo Therapeutics announced Monday the first commercial sales of its “electroceutical” wearable electronic device for pain relief.
Amgen Inc. and partner Allergan plc announced Thursday they were given marketing authorization by the European Commission for the drug Mvasi to treat certain types of cancers.
Atara Biotherapeutics Inc. capped off a strong week with a soaring stock price on Friday, when shares of the biopharmaceutical firm rose nearly 30 percent to a two-year high.
Endonovo Therapeutics Inc. has engaged a company to monitor trading of its shares, the company announced Thursday.